Notably, the antimalarial agent mefloquine was found to induce LMP and release of cathepsins into the cytoplasm of human acute myeloid leukemia (AML) cells, which provides a novel and promising therapeutic strategy for AML (Sukhai et al., 2013). The gene discussed is CTSS; the disease is acute myeloid leukemia.